DIVAA Third Phase, Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults

Fecha de inicio: 1 de mayo de 2010

Inclusion Criteria: * Adult * Recovering of written and dated informed consent form * Social Security medical cover * Left Iliac Fossa (LIF) pain * Moderate fever (\>37.8°C) * Sensitivity/defence during LIF palpation Biological results : * CRP \> 10mg/L * NFS \> 10G/L * Neutrophil Granulocytosis \> 75% * Radiological results - presence to the scan :diverticul \& pericolic infiltration Exclusion Criteria: * Patients treated by antibiotherapy in the last 15 days prior inclusion * Patients treated by morphinic drug * Patients treated by anticoagulant drug * Pregnant or breast-feeding women * Patients presenting allergy to active principal, to galactose * Patients having taking part in another study in the last 3 months prior inclusion * Patients unable to comply with the study requirements * Patients presenting Chronic affection inconsistent with the study * Patients presenting high fever * Patients presenting abdominal contracture * Patients presenting immunosuppression * Radiological sign of complication (abscess\>3cm) * Patients presenting Pathology inconsistent with efficacy evaluatio